143 related articles for article (PubMed ID: 28472430)
1. EVALUATION OF SECONDARY DOSE AND CANCER RISK FOR OUT-OF-FIELD ORGAN IN ESOPHAGEAL CANCER IMRT IN A CHINESE HOSPITAL USING ATOM PHANTOM MEASUREMENTS.
Qi Y; He L; Wang Z; Liu Y; Liu H; Huo W; Xu XG; Chen Z
Radiat Prot Dosimetry; 2017 Dec; 177(4):389-396. PubMed ID: 28472430
[TBL] [Abstract][Full Text] [Related]
2. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.
Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M
J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.
Yoon M; Ahn SH; Kim J; Shin DH; Park SY; Lee SB; Shin KH; Cho KH
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1477-85. PubMed ID: 19879701
[TBL] [Abstract][Full Text] [Related]
4. OUT-OF-FIELD DOSE MEASUREMENTS FOR 3D CONFORMAL AND INTENSITY MODULATED RADIOTHERAPY OF A PAEDIATRIC BRAIN TUMOUR.
Majer M; Stolarczyk L; De Saint-Hubert M; Kabat D; Kneževic Ž; Miljanic S; Mojzeszek N; Harrison R
Radiat Prot Dosimetry; 2017 Nov; 176(3):331-340. PubMed ID: 28338841
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy-induced secondary cancer risk for breast cancer: 3D conformal therapy versus IMRT versus VMAT.
Lee B; Lee S; Sung J; Yoon M
J Radiol Prot; 2014 Jun; 34(2):325-31. PubMed ID: 24705154
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with EPID dosimetry for prostate IMRT pre-treatment dose verification.
McDermott LN; Wendling M; van Asselen B; Stroom J; Sonke JJ; van Herk M; Mijnheer BJ
Med Phys; 2006 Oct; 33(10):3921-30. PubMed ID: 17089854
[TBL] [Abstract][Full Text] [Related]
7. Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis.
Ruben JD; Smith R; Lancaster CM; Haynes M; Jones P; Panettieri V
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):645-53. PubMed ID: 25084609
[TBL] [Abstract][Full Text] [Related]
8. MEASUREMENT OF ABSORPTION DOSE OUTSIDE IRRADIATION FIELD IN IMRT.
Hirata M; Monzen H; Hanaoka K; Nishimura Y
Radiat Prot Dosimetry; 2017 Nov; 176(4):425-433. PubMed ID: 28338869
[TBL] [Abstract][Full Text] [Related]
9. MONTE CARLO SIMULATION OF OUT-OF-FIELD ORGAN DOSES AND CANCER RISK IN TANZANIA FOR RADIATION THERAPY OF UNILATERAL RETINOBLASTOMA USING A 60Co UNIT.
Suleiman SA; Qi Y; Pi Y; George Xu X
Radiat Prot Dosimetry; 2018 May; 179(3):263-270. PubMed ID: 29216393
[TBL] [Abstract][Full Text] [Related]
10. The risk of secondary cancer in nasopharyngeal carcinoma paediatric patients due to intensity modulated radiotherapy and mega-voltage cone beam computed tomography.
Sherif RS; Attalla EM; Elshemey WM; Madian NG
J Med Imaging Radiat Oncol; 2017 Jun; 61(3):402-409. PubMed ID: 28019086
[TBL] [Abstract][Full Text] [Related]
11. Radiobiologic comparison of helical tomotherapy, intensity modulated radiotherapy, and conformal radiotherapy in treating lung cancer accounting for secondary malignancy risks.
Komisopoulos G; Mavroidis P; Rodriguez S; Stathakis S; Papanikolaou N; Nikiforidis GC; Sakellaropoulos GC
Med Dosim; 2014; 39(4):337-47. PubMed ID: 25168596
[TBL] [Abstract][Full Text] [Related]
12. Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy.
Simonetto C; Rennau H; Remmele J; Sebb S; Kundrát P; Eidemüller M; Wolf U; Hildebrandt G
Strahlenther Onkol; 2019 Jan; 195(1):32-42. PubMed ID: 30350118
[TBL] [Abstract][Full Text] [Related]
13. Out-of-field doses from pediatric craniospinal irradiations using 3D-CRT, IMRT, helical tomotherapy and electron-based therapy.
De Saint-Hubert M; Verellen D; Poels K; Crijns W; Magliona F; Depuydt T; Vanhavere F; Struelens L
Phys Med Biol; 2017 Jul; 62(13):5293-5311. PubMed ID: 28398210
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
[TBL] [Abstract][Full Text] [Related]
15. Out-of-field organ doses and associated radiogenic risks from para-aortic radiotherapy for testicular seminoma.
Mazonakis M; Berris T; Varveris C; Lyraraki E; Damilakis J
Med Phys; 2014 May; 41(5):051702. PubMed ID: 24784368
[TBL] [Abstract][Full Text] [Related]
16. A comparison of out-of-field dose and its constituent components for intensity-modulated radiation therapy versus conformal radiation therapy: implications for carcinogenesis.
Ruben JD; Lancaster CM; Jones P; Smith RL
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1458-64. PubMed ID: 20950947
[TBL] [Abstract][Full Text] [Related]
17. COMPARISON OF THE PERIPHERAL DOSES FROM DIFFERENT IMRT TECHNIQUES FOR PEDIATRIC HEAD AND NECK RADIATION THERAPY.
Toyota M; Saigo Y; Higuchi K; Fujimura T; Koriyama C; Yoshiura T; Akiba S
Radiat Prot Dosimetry; 2017 Nov; 176(3):322-330. PubMed ID: 28338854
[TBL] [Abstract][Full Text] [Related]
18. Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.
Candela-Juan C; Perez-Calatayud J; Ballester F; Rivard MJ
Med Phys; 2013 Mar; 40(3):033901. PubMed ID: 23464344
[TBL] [Abstract][Full Text] [Related]
19. Accuracy and sources of error of out-of field dose calculations by a commercial treatment planning system for intensity-modulated radiation therapy treatments.
Huang JY; Followill DS; Wang XA; Kry SF
J Appl Clin Med Phys; 2013 Mar; 14(2):4139. PubMed ID: 23470942
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of organ-specific peripheral doses after 2-dimensional, 3-dimensional and hybrid intensity modulated radiation therapy for breast cancer based on Monte Carlo and convolution/superposition algorithms: implications for secondary cancer risk assessment.
Joosten A; Matzinger O; Jeanneret-Sozzi W; Bochud F; Moeckli R
Radiother Oncol; 2013 Jan; 106(1):33-41. PubMed ID: 23351844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
